已发表论文

TEAD 家族在卵巢浆液性癌诊断、预后及免疫应答中的意义

 

Authors Ren X , Wang X, Peng B, Liang Q, Cai Y, Gao K, Hu Y, Xu Z , Yan Y

Received 3 September 2021

Accepted for publication 19 October 2021

Published 27 October 2021 Volume 2021:14 Pages 7133—7143

DOI https://doi.org/10.2147/IJGM.S336602

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser

Purpose: To explore the molecular profiles of transcriptional enhanced associate domain (TEAD ) family in ovarian serous carcinoma (OSC).
Methods: In this study, we use bioinformatics methods including GEPIA, GE-mini, Oncomine 3.0, Kaplan–Meier plotter, cBioPortal, WebGestalt, TIMER2.0 and DiseaseMeth2.0, and in vitro experimental RT-PCR to assess the expression profiles and prognostic significance of TEAD  family in OSC.
Results: According to the bioinformatics analysis, TEAD  family was abnormally expressed in OSC. In terms of prognosis, Kaplan–Meier plotter indicated that OSC patients with high level of TEAD4 showed poor overall survival (OS), progression-free survival (PFS) and post progression survival (PPS). TEAD  family also had significantly diagnostic values for OSC patients. Tumor Immune Estimation Resource (TIMER) algorithm indicated that TEAD  family was significantly associated with different types of infiltrating immune cells, including B cells, macrophages, dendritic cells, neutrophils, CD8+ T cells and CD4+ T cells. Gene set enrichment analysis of TEAD  family-associated coexpression genes was further explored. In in vitro experiments, the RT-PCR results showed the upregulated TEAD2/4 in OSC tissues and cells (A2780 and TOV112D). Moreover, decreased expression of TEAD2 could induce the ferroptosis through increasing the ROS accumulation.
Conclusion: Thus, TEAD  family correlated with the diagnosis, prognosis and immune infiltration in OSC. These results could provide comprehensive understanding of TEAD  family in the diagnosis and prognosis of OSC patients.
Keywords: TEAD  family, Hippo pathway, ovarian serous carcinoma, expression profiles, prognosis, immune infiltration